Abstract:Type I interferons (IFNα/β) regulate diverse aspects of host defense, but their impact on hematopoietic stem and progenitor cells (HSC/HSPCs) during infection remains unclear. Hematologic impairment can occur in severe infections, thus we sought to investigate the impact of type I IFNs on hematopoiesis in a tick-borne infection with a virulent ehrlichial pathogen that causes shock-like disease. During infection, IFNα/β induced severe bone marrow (BM) loss, blunted infection-induced emergency myelopoiesis, and reduced phenotypic HSPCs and HSCs. In the absence of type I IFN signaling, BM and splenic hematopoiesis were increased, and HSCs derived from Ifnar1-deficient mice were functionally superior in competitive BM transplants. Type I IFNs impaired hematopoiesis during infection by both limiting HSC/HSPC proliferation and increasing HSPC death. Using mixed BM chimeras we determined that type I IFNs restricted proliferation indirectly, whereas HSPC death occurred via direct IFNαR -mediated signaling. IFNαR-dependent signals resulted in reduced caspase 8 expression and activity, and reduced cleavage of RIPK1 and RIPK3, relative to Ifnar1-deficient mice. RIPK1 antagonism with Necrostatin-1s rescued HSPC and HSC numbers during infection. Early antibiotic treatment is required for mouse survival, however antibiotic-treated survivors had severely reduced HSPCs and HSCs. Combination therapy with antibiotics and Necrostatin-1s improved HSPC and HSC numbers in surviving mice, compared to antibiotic treatment alone. We reveal two mechanisms whereby type I IFNs drive hematopoietic collapse during severe infection: direct sensitization of HSPCs to undergo cell death and enhanced HSC quiescence. Our studies reveal a strategy to ameliorate the type I IFN-dependent loss of HSCs and HSPCs during infection, which may be relevant to other infections wherein type I IFNs cause hematopoietic dysfunction.

Interferon-sensitized hematopoietic progenitors dynamically alter organismal immunity

Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review

Type 1 interferon perturbates clonal competition by reshaping human blood development

Aberrant inflammatory responses to type I interferon in STAT2 or IRF9 deficiency

Type I IFNs Drive Hematopoietic Stem and Progenitor Cell Collapse Via Impaired Proliferation and Increased RIPK1-dependent Cell Death During Shock-Like Ehrlichial Infection.

Single Cell Transcriptomic Dissection of Virus Induced Immunopathology in Interferon Gamma Receptor Null Mice

Single-cell time series analysis reveals the dynamics of HSPC response to inflammation

IFN-γ–STAT1–iNOS Induces Myeloid Progenitors to Acquire Immunosuppressive Activity

Inflammation perturbs hematopoiesis by remodeling specific compartments of the bone marrow niche

Inflammatory Signaling Regulates Embryonic Hematopoietic Stem and Progenitor Cell Production.

Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons

Interferon target-gene expression and epigenomic signatures in health and disease

IFNα activates dormant haematopoietic stem cells in vivo

Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment

Prolonged exposure to type-I IFN inhibits IL-10 signaling in memory and regulatory T cells: a new mechanism contributing to the development of autoimmune diseases (BA13P.130)

Towards an integrated understanding of inflammatory pathway influence on hematopoietic stem and progenitor cell differentiation

Transient inhibition of type I interferon enhances CD8+ T cell stemness and vaccine protection

Type I interferons and autoimmunity: lessons from the clinic and from IRF-2-deficient mice

Type I interferon governs immunometabolic checkpoints that coordinate inflammation during infection

Immuno-Modulation of Hematopoietic Stem and Progenitor Cells in Inflammation

Brief Report: Interferon-Gamma Induces Expansion of Lin(-)Sca-1(+)C-Kit(+) Cells